@Targeted2022 profile picture
TargetedResponse @Targeted2022
Joined February 2022
  • Tweets 93
  • Following 29
  • Followers 20
46 Photos and videos
Pinned Tweet
TargetedResponse@Targeted2022
28 Apr 2022
šŸ„³šŸ„³šŸ„³ #fondzanauku #TARGRES #programideje #IBISS #MFUB We are so excited to announce that our new website is now live āœØ Visit it and learn more about the objectives of our project, team members, and more! targetedresponse.ibiss.bg.acā€¦
1
Dr. Milica PeÅ”ić, the PI of TartetedResponse, attended IBISS Biomedicine Research and Collaboration Capacity at Rocheā€™s RISE Event.
2
1
74
The achievements of IBISS were highlighted through presentations by Dr. Milica PeÅ”ić, Dr. Danijela Maksimović-Ivanić, Dr. Aleksandra Uskoković, and Dr. Aleksandra Mladenović, demonstrating their impactful contributions to the biomedical research in Serbia and beyond.
87
Roche's initiative RISE hosted a one-day event in Ložionica, Beograd, on 27 September, aimed at bridging the gap between innovation in clinical practice and collaborative research. The programme featured several sessions tailored for experts in the field.
36
šŸ”™āœØ Throwback highlights from #TargetedResponse project!
2
1
17
šŸŽ™ļø We're also proud to highlight the interview with our Principal Investigator, Dr. Milica PeÅ”ić, featured in a news portal, where she shared insights about our projectā€™s goals, challenges, and impact.
1
39
šŸ“ In May 2022, Dr. Miodrag Dragoj completed a short-term scientific mission at the Institute for Cancer Research, Medical University of Vienna, Austria. During his stay (May 4ā€“30), he received specialized training in bioinformatics for DNA sequencing data.
20
šŸ“¢ The #TargetedResponse team has published a new article in Oncologie, titled ''Impact of ex vivo cell culturing on ABC transportersā€™ expression and drug sensitivity in patient-derived non-small cell lung cancer models''. DOI: 10.1515/oncologie-2025-0228 #fondzanauku #IDEJE
22
šŸ”¬ Throwback to some of the inspiring scientific meetings where #TargetedResponse team showcased our work!
1
18
Zagreb, Croatia, 2024 Dr. Ana Podolski-Renić took the stage at The 7th HDIR Meeting, presenting how our research is bringing personalized therapy for NSCLC one step closer to clinical reality. (ā€˜ā€™Functional diagnostics in personalized therapy for non-small cell lung carcinomaā€™ā€™)
3
36
Coimbra, Portugal, 2022 At The 5th Annual STRATAGEM Meeting, Dr. Miodrag Dragoj shared our vision on how functional diagnostics can revolutionize targeted cancer treatments.(ā€˜ā€™Functional diagnostics as a new concept for the improvement of personalized targeted therapyā€™ā€™)
25
paris, France, 2023 Dr. Jelena Dinić represented the team at ESMO Open, presenting our findings on functional diagnostics and ex-vivo drug screening in NSCLC ā€” paving the way for tackling multidrug resistance and advancing personalized therapy.
17
Belgrade, Serbia, 2024 At The 5th Belgrade Bioinformatics Conference (BelBI), Dr. Miodrag Dragoj presented our work on integrating functional diagnostics and bioinformatics for a smarter, more personalized approach to cancer treatment.
23
Članica tima TargetedResponse Ana Stepanović je jedna od ovogodiÅ”njih dobitnica SDIR nagrade za najbolju publikaciju u oblasti istraživanja raka za 2025. godinu. Čestitamo Ani! #fondzanauku #IDEJE #TargetedResponse #programideje
1
23
TargetedResponse team member Ana Stepanović is one of this year's winners of the SDIR award for best publication in cancer research for 2025. Congratulations to Ana!
15
šŸ“¢ The #TargetedResponse team has published a new article in Current Issues in Molecular Biology, focusing on personalized treatment strategy in non-small cell lung carcinoma (NSCLC). šŸ”— Read the full article here: mdpi.com/1467-3045/47/4/281
1
21
šŸ“¢ Tim #TargetedResponse objavio je novi članak u časopisu Current Issues in Molecular Biology, koji se fokusira na personalizovani pristup u lečenju nesitnoćelijskog karcinoma pluća. šŸ”— Pročitajte ceo članak ovde: mdpi.com/1467-3045/47/4/281

Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an...

Background/Objectives: Non-small cell lung carcinoma (NSCLC) is characterized by its diverse molecular profiles and varying responses to treatment, highlighting the importance of precision medicine...

mdpi.com
15
Članice tima #TargetedResponse, dr Milica PeÅ”ić i dr Ana Podolski-Renić, prezentovale su deo rezultata projekta na ABC2025 konferenciji u Insbruku.
1
28
Member's of the #TargetedResponse team, Dr. Milica PeÅ”ić and Dr. Ana Podolski-Renić, presented the project results at ABC2025 conference at Innsbruck.
31
We would like to express our gratitude to all participants for their valuable collaboration during the #TargetedResponse project webinar. Your contribution and active involvement in the discussions were key to the event's success!
1
13
Here are the survey graphics illustrating diversity of participating institutions and the participant composition overview.
7
Load more